🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Donna McEachern

University of Michigan

ORCID: 0000-0001-8662-3425
Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Discovery of SD-436: A Potent, Highly Selective and Efficacious STAT3 PROTAC Degrader Capable of Achieving Complete and Long-Lasting Tumor Regression”.

Discovery of SD-436: A Potent, Highly Selective and Efficacious STAT3 PROTAC Degrader Capable of Achieving Complete and Long-Lasting Tumor Regression

Journal of Medicinal Chemistry(2024)10.1021/acs.jmedchem.4c01946
N/A
0.483DataRank · unranked
24 citations

Haibin Zhou, Longchuan Bai, Donna McEachern, Dimin Wu, Ranjan Kumar Acharyya +12 more

Development of PVTX-405 as a potent and highly selective molecular glue degrader of IKZF2 for cancer immunotherapy

Nature Communications(2025)10.1038/s41467-025-58431-z
N/A
0.464DataRank · unranked
21 citations

Harshil Dhruv, Xuqing Zhang, Rohan Kalyan Rej, Longchuan Bai, Donna McEachern +14 more

Discovery of ARD-2051 as a Potent and Orally Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer

Journal of Medicinal Chemistry(2023)10.1021/acs.jmedchem.3c00405
N/A
0DataRank · unranked
58 citations

Lijie Zhao, Weiguo Xiang, Bukeyan Miao, Chong Qin, Mi Wang +16 more

Precise Conformational Control Yielding Highly Potent and Exceptionally Selective BRD4 Degraders with Strong Antitumor Activity

Journal of Medicinal Chemistry(2023)10.1021/acs.jmedchem.3c00520
N/A
0DataRank · unranked
27 citations

Biao Hu, Fuming Xu, Mi Wang, Chong Qin, Donna McEachern +3 more

Discovery of ERD-1233 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader for the Treatment of ER+ Human Breast Cancer

Journal of Medicinal Chemistry(2024)10.1021/acs.jmedchem.4c01521
N/A
0DataRank · unranked
21 citations

Rohan Kalyan Rej, Biao Hu, Zhixiang Chen, Dimin Wu, Jianfeng Lü +18 more

Correction to “Discovery of ERD-1233 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader for the Treatment of ER+ Human Breast Cancer”

Journal of Medicinal Chemistry(2025)10.1021/acs.jmedchem.5c00592
N/A
0DataRank · unranked
1 citations

Rohan Kalyan Rej, Biao Hu, Zhixiang Chen, Dimin Wu, Jianfeng Lü +18 more

Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer

Journal of Medicinal Chemistry(2021)10.1021/acs.jmedchem.1c00900
N/A
0DataRank · unranked
142 citations

Lijie Zhao, Xin Han, Chong Qin, Bukeyan Miao, Donna McEachern +10 more

Balance between STAT5 and STAT3 determines dendritic cell function and tumor immunity 2337

The Journal of Immunology(2025)10.1093/jimmun/vkaf283.264
N/A
0DataRank · unranked
0 citations

Kole Tison, Haibin Zhou, Longchuan Bai, Ranjan Kumar Acharyya, Donna McEachern +22 more

Strategies toward Discovery of Potent and Orally Bioavailable Proteolysis Targeting Chimera Degraders of Androgen Receptor for the Treatment of Prostate Cancer

Journal of Medicinal Chemistry(2021)10.1021/acs.jmedchem.1c00882
N/A
0DataRank · unranked
139 citations

Lijie Zhao, Weiguo Xiang, Chong Qin, Bukeyan Miao, Donna McEachern +8 more